Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katherine J. Ryan
Observed names:
Katherine J Ryan,
Katherine Ryan
Institutions:
Lucile Packard Children's Hospital,
Stanford Medicine,
Stanford University
Observed institutions:
Lucile Packard Children's Hospital,
Duke University,
Duke Medical Center,
Stanford Medicine,
Duke University Health System,
Duke University Hospital,
Stanford University
show all 7
ORCID:
0000-0003-0699-0968
Observed ORCID:
0000-0003-0699-0968
OpenAlex ID:
A5089593057
CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2022
·
Quinn T Ostrom
, Mackenzie Price
, et al.
·
Neuro-Oncology
·
346
Immune suppression in gliomas
2020
·
Matthew M. Grabowski
, Eric W. Sankey
, et al.
·
Journal of Neuro-Oncology
·
287
PDF
Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019
2023
·
Mackenzie Price
, Katherine Ryan
, et al.
·
Neuro-Oncology Practice
·
47
PDF
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly
2022
·
William B. Hannah
, Katherine Ryan
, et al.
·
American Journal of Medical Genetics Part A
·
2
Docetaxel‐Induced Myositis in a 16‐Year‐Old Male With Rhabdomyosarcoma: Case Report and Literature Review
2026
·
Rohaum Hamidi
, Katherine E. Masih
, et al.
·
Pediatric Blood & Cancer
·
1
Exth-39. D2c7-car: a Novel, Dual-specific Chimeric Antigen Receptor T Cell With High Specificity for Egfr and Egfrviii Improves Survival in Egfr/egfrviii Glioblastoma and Egfr Over-expressing Medulloblastoma
2023
·
Zach Wilson
, Daniel Wilkinson
, et al.
·
Neuro-Oncology
·
1
PDF
Glial Maturation and Immune Landscape Dynamics in MN1::PATZ1 Fusion-Positive CNS Tumor Recurrence
2026
·
Emon Nasajpour
, Ruolun Wei
, et al.
·
medRxiv
EXTH-142. Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy
2025
·
Diren Usta
, William Gwynne
, et al.
·
Neuro-Oncology
PDF
Syst-14 D2c7 Car Effectively and Safely Treats Egfrwt and Egfrviii-expressing Tumors Following Intracranial Administration
2023
·
Daniel Wilkinson
, Joseph Wilson
, et al.
·
Neuro-Oncology Advances
PDF
Exth-84. a Novel Dual-specific Chimeric Antigen Receptor T Cell With High Specificity for Egfr and Egfrviii Improves Survival in Egfr Expressing Medulloblastoma
2022
·
Joseph Wilson
, Daniel Wilkinson
, et al.
·
Neuro-Oncology
PDF
Syst-12 D2c7 Car: a Novel Car T Cell That Simultaneously Targets Wildtype Egfr and Its Mutant Isoform Egfrviii for Treatment of Glioma and Brain Metastases
2022
·
Daniel Wilkinson
, Katherine Ryan
, et al.
·
Neuro-Oncology Advances
D2C7 CAR: A novel CAR T cell that simultaneously targets wildtype EGFR and its mutant isoform EGFRvIII for treatment of glioma
2022
·
Daniel S Wilkinson
, Katherine Ryan
, et al.
·
The Journal of Immunology
Exth-59. Generation of a Third Generation Car T Cell That Simultaneously Targets Wildtype Egfr and Its Mutant Isoform Egfrviii for Treatment of Glioblastoma
2021
·
Daniel Wilkinson
, Katherine Ryan
, et al.
·
Neuro-Oncology
PDF
DDRE-20. GENERATION OF A HIGH-AFFINITY EGFR/EGFRvIII-TARGETED D2C7 CAR-T CELL
2020
·
Katherine Ryan
, Daniel Wilkinson
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
14
Citation count:
684
H-index:
3
I10-index:
3
Year
Topic
Type